Literature DB >> 11389305

Managing stimulant medication for attention-deficit/hyperactivity disorder.

E H Wender1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389305     DOI: 10.1542/pir.22-6-183

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


× No keyword cloud information.
  2 in total

1.  Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder.

Authors:  Christopher L Robinson; Katelyn Parker; Saurabh Kataria; Evan Downs; Rajesh Supra; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-23

2.  Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: Report from a referral center.

Authors:  Zahra Khajehpiri; Javad Mahmoudi-Gharaei; Toktam Faghihi; Iman Karimzadeh; Hossein Khalili; Mostafa Mohammadi
Journal:  J Res Pharm Pract       Date:  2014-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.